Healthcare · Pharmaceuticals & Biotechnology
No company profile on record yet.
| Fiscal year | Mar 26 |
|---|---|
| Total income (before exceptional items) | — |
| Net profit | 17 |
₹ Crore. † Summed from the four quarterly filings of that fiscal year.
Current board roster from exchange filings. Director remuneration is not in our data, so it isn't shown.
| Name | Designation | Term end |
|---|---|---|
| Anil Kumar Karusala | Executive Director | June 30, 2026 |
| Vijitha Gorrepati | Executive Director | June 30, 2026 |
| Bhagyashri Dharmasa Zad | Independent Director | June 30, 2026 |
| Kalidindi V Raju | Independent Director | June 30, 2026 |
| Seeta Ram Anjaneyulu Gorantla | Independent Director | June 30, 2026 |
| Aruna Karusala | Non-Executive Director | June 30, 2026 |
Key management names, their remuneration, subsidiaries and brand listings are not in the exchange filings we ingest yet, so they are not shown here rather than estimated.
